Futu News reported on June 9 that all three major HK stock indices rose,$Hang Seng Index (800000.HK)$ up 1.63%, $Hang Seng TECH Index (800700.HK)$ up 2.78%, $Hang Seng China Enterprises Index (800100.HK)$up 1.74%.
As of the market close, there were 1,392 stocks rising, 773 stocks falling, and 972 stocks remaining flat.
The specific performance of the industry is shown in the figure below:
In the Sector, Network Technology stocks rose, with KUAISHOU-W up 5.58%, MEITUAN-W up 4.73%, JD-SW up 4.12%, NTES-S up 3.02%, Baidu Group-SW up 2.93%, Alibaba-W up 2.32%, XIAOMI-W up 1.98%, and TENCENT up 0.58%.
New consumption stocks are rising, with POP MART increasing by over 2%, reaching a new high; MIXUE GROUP rising over 5%, and Bloks Group increasing over 22%.
Rare Earth Metals concept stocks surged, with Jl Mag Rare-Earth rising nearly 2% and CHINA RAREEARTH increasing by 60%.
Biotechnology stocks all rose, with GENSCRIPT BIO increasing by 16.14%, CLOUD TOP NEW MATERIALS up 14.48%, SOLOMON SYSTECH rising 7.16%, AKESO up 6.08%, WUXI BIO rising 5.48%, BEIGENE up 4.04%, REMEGEN increasing by 3.73%, and 3SBIO rising 0.43%.
Digital Health stocks rose, with DINGDANG HEALTH up 14.29%, ZA ONLINE up 5.49%, JD HEALTH up 4.04%, PA GOODDOCTOR up 3.80%, and ALI HEALTH up 3.78%.
Semiconductor stocks all rose, with SOLOMON SYSTECH increasing by 8.43%, BEKE MICRO up 6.55%, Semiconductor Manufacturing International Corporation up 5.10%, INGDAN up 4.62%, SHANGHAI FUDAN down 2.77%, HUA HONG SEMI up 2.52%, INNOSILICON up 1.45%, and CE HUADA TECH increasing by 0.67%.
Pharmaceutical stocks all rose, with HEC CJ PHARM increasing by 9.49%, GRANDPHARMA rising 8.93%, LUYE PHARMA up 8.50%, 3SBIO up 8.17%, INNOVENT BIO up 8.00%, SINO BIOPHARM rising 4.18%, SIMCERE PHARMA up 3.21%, and CSPC PHARMA down 0.45%.
Apple Concept stocks performed brightly, with COWELL up 5.17%, SUNNY OPTICAL up 4.91%, Q TECH up 3.34%, AAC TECH up 3.17%, FIH down 2.11%, BYD ELECTRONICS up 2.03%, TK GROUP HLDG up 1.94%, and VSTECS up 0.47%.
In terms of individual stocks, $MEITUAN-W (03690.HK)$Up nearly 5%, recently announced the official operation of the first regular drone route in Hong Kong.
$HKEX (00388.HK)$Up over 3%, with a surge in Hong Kong IPOs, Morgan Stanley has raised the Target Price to 500 Hong Kong dollars.
$CHINA RAREEARTH (00769.HK)$Volume surged 60%, with relaxation in rare earth exports, the company mainly engages in the manufacturing and sales of rare earth and refractory products.
$PARADISE ENT (01180.HK)$In the afternoon, there was a significant volume drop, falling over 47% before the suspension, with the company focusing on the research and manufacturing of entertainment machines.
$CHI SILVER GP (00815.HK)$It rose over 13% again, with the stock price accumulating over 70% increase this month, and Silver surged 9% last week to reach $36.
Today's TOP 10 transaction amount.
Funds from Hong Kong Stock Connect.
Regarding Hong Kong Stock Connect, today's net inflow from southbound trading is 0.717 billion HKD.
Institution Ratings
DBS: Raised the Target Price for CHINA TELECOM to HKD 7.1, maintaining a 'Buy' rating.
DBS Bank released a research report stating that it expects $CHINA TELECOM (00728.HK)$ the dividend payout ratio to rise to 75% in the fiscal year 2026, supporting a dividend yield of about 5%. It expects an annual compound growth rate of earnings of 8% from fiscal years 2024 to 2027, driven by stable business and reduced depreciation and amortization expenses. Due to the rapid expansion of its industrial digitalization business and a robust dividend yield of about 5%, the bank maintains a 'Buy' rating on CHINA TELECOM, raising the Target Price from HKD 6.1 to HKD 7.1, equivalent to a PE ratio of 17 times for fiscal year 2025, which is 15% higher than regional telecom peers, benefiting from AI and data center revenue contributing about 5%, supported by national AI developments in China.
Goldman Sachs: KUAISHOU-W's KOLING AI second quarter revenue trend exceeds expectations, rating 'Buy.'
Goldman Sachs published a research report stating that $KUAISHOU-W (01024.HK)$ the annualized revenue run rate for its KOLING AI surpassed USD 0.1 billion in March, and monthly payments in April and May also exceeded RMB 0.1 billion. It is believed that the run rate will surpass company guidance and market expectations. The bank projects that KOLING AI's revenue for fiscal year 2025 will exceed USD 0.12 billion and will continue to grow rapidly thereafter. The bank assigns a 'Buy' rating to KUAISHOU-W with a Target Price of HKD 63.
Citi maintains a "Buy" rating on BYD, expecting inventory levels to decrease further.
Citi published a research report stating that, assuming $BYD COMPANY (01211.HK)$ In May, domestic retail sales reached 0.287 million vehicles, predicting that as of the end of May this year, BYD's domestic inventory would stabilize at 0.609 million vehicles (2.12 months). To achieve the market forecast of 5.5 million vehicles in wholesale volume for the whole year and avoid excessive year-end inventory, the bank expects BYD's domestic retail sales in the second to fourth quarters of this year to grow quarter-on-quarter by 25%, 36.4%, and 34.5% respectively, with total sales of 4.26 million vehicles, and export volume reaching 1 million vehicles, prompting the company’s inventory level at the end of this year to further decrease to 1.26 months. Citi maintains a "Buy" rating on BYD.
Editor/danial
